David Williams - Merck Ex Officer
| MRK Stock | EUR 95.60 0.90 0.93% |
Insider
David Williams is Ex Officer of Merck Company
| Age | 54 |
| Phone | 908 740 4000 |
| Web | https://www.merck.com |
David Williams Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Williams against Merck stock is an integral part of due diligence when investing in Merck. David Williams insider activity provides valuable insight into whether Merck is net buyers or sellers over its current business cycle. Note, Merck insiders must abide by specific rules, including filing SEC forms every time they buy or sell Merck'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Williams over a year ago Bona fide gift to David Williams of 377 shares of NACCO Industries subject to Section 16 | ||
David Williams over a year ago NACCO Industries exotic insider transaction detected | ||
David Williams over a year ago Bona fide gift to David Williams of 207 shares of NACCO Industries subject to Section 16 | ||
David Williams over a year ago Acquisition by David Williams of 5457 shares of Regis subject to Rule 16b-3 |
Merck Management Efficiency
The company has return on total asset (ROA) of 0.1268 % which means that it generated a profit of $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.351 %, meaning that it generated $0.351 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Magistrate Pachinger | Oberbank AG | N/A | |
| Susanne Langer | Raiffeisen Bank International | N/A | |
| Andrii Stepanenko | Raiffeisen Bank International | 51 | |
| Hannes Mosenbacher | Raiffeisen Bank International | 51 | |
| MBA MBA | Oberbank AG | 60 | |
| M GuerinMoens | SBM Offshore NV | N/A | |
| Peter Thirring | Vienna Insurance Group | 66 | |
| Harald Schnauer | Raiffeisen Bank International | 47 | |
| Magistrate Gschwenter | Raiffeisen Bank International | 54 | |
| Carmen Staicu | Erste Group Bank | N/A | |
| Magistrate Hirner | Vienna Insurance Group | 55 | |
| Magistrate Bleier | Erste Group Bank | 53 | |
| Stein Rasmussen | SBM Offshore NV | N/A | |
| Lukasz Januszewski | Raiffeisen Bank International | 45 | |
| Olivier Icyk | SBM Offshore NV | N/A | |
| Magistrate MBA | Oberbank AG | N/A | |
| Johann Strobl | Raiffeisen Bank International | 64 | |
| Thomas Sommerauer | Erste Group Bank | 51 | |
| Vincent Kempkes | SBM Offshore NV | N/A | |
| Magistrate Mag | Erste Group Bank | 53 | |
| Magistrate Lahner | Vienna Insurance Group | 46 | |
Management Performance
| Return On Equity | 0.35 | |||
| Return On Asset | 0.13 |
Merck Company Leadership Team
Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cristal Downing, Ex Officer | ||
| Jennifer Zachary, General Counsel | ||
| David Williams, Ex Officer | ||
| Caroline Litchfield, Ex CFO | ||
| Lisa LeCointeCephas, VP Officer | ||
| Richard DeLuca, Executive Vice President and Presidentident - Merck Animal Health | ||
| Kenneth Frazier, Chairman of the Board and Presidentident, CEO | ||
| Peter Dannenbaum, VP Relations | ||
| Jennifer Mauer, VP Communications | ||
| Robert JD, Pres Chairman |
Merck Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merck a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.35 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.38 % | |||
| Current Valuation | 286.52 B | |||
| Shares Outstanding | 2.54 B | |||
| Shares Owned By Insiders | 0.10 % | |||
| Shares Owned By Institutions | 76.37 % | |||
| Price To Earning | 21.59 X | |||
| Price To Book | 6.31 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Merck Stock
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.